Ryusuke Yamamoto

Kobe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Journal: International journal of hematology

Published: August 19, 2025

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.

Journal: Scientific reports

Published: June 28, 2025

Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.

Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.

Journal: American journal of hematology

Published: June 20, 2025

Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid Leukemia.

Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid Leukemia.

Journal: European journal of haematology

Published: May 24, 2025

A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Journal: International journal of hematology

Published: January 06, 2025

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma.

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma.

Journal: Cancer science

Published: September 27, 2024

Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience.

Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience.

Journal: International journal of hematology

Published: September 16, 2024

Punched-out Lesions of the Pelvic and Femur Bones.

Punched-out Lesions of the Pelvic and Femur Bones.

Journal: Internal medicine (Tokyo, Japan)

Published: June 05, 2024

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: November 13, 2023

Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies.

Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies.

Journal: British journal of haematology

Published: October 24, 2023

Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.

Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.

Journal: Transplantation and cellular therapy

Published: July 13, 2023

Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis.

Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis.

Journal: Blood cancer journal

Published: June 14, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026